Just started on dutasteride after finesteride has not worked Finasteride/Dutasteride 7/29/2025
The user switched from finasteride and topical minoxidil to dutasteride and oral minoxidil due to lack of results. They are hopeful about dutasteride but are prepared to stop all medication if it doesn't work, as they have aggressive hair loss genetics.
View this post in the Community →
Similar Community Posts Join
5 / 5 resultscommunity Minoxidil temple and hairline results, true progress or placebo? as well as a few other questions
A 19-year-old with aggressive hair loss genetics is using topical minoxidil and finasteride, considering switching to oral minoxidil for better results. Users suggest sticking with the current regimen due to visible progress and keeping oral minoxidil as a future option.
community 18m 1mg fin and 2.5 mg oral min 255 days since i’ve noticed shedding started taking meds 161 days ago still shedding like crazy
An 18-year-old experiencing aggressive hair loss has been using 1mg finasteride and 2.5mg oral minoxidil for 162 days but continues to shed hair. Suggestions include switching to dutasteride, considering topical minoxidil, and consulting a dermatologist for further evaluation.
community If dutesteride and oral minoxidil doesn’t work that’s it right?
A user is experiencing ongoing hair loss despite using 0.5mg dutasteride and 2.5mg oral minoxidil for several years and is seeking advice. Suggestions include ensuring correct diagnosis, checking for other health issues, considering finasteride, trying topical antiandrogens, and consulting a dermatologist.
community No regrowth after oral min, topical fin, min, and tret: Aggressive diffuse/hairline recession in 2 years
A user experienced no hair regrowth after using oral minoxidil, topical finasteride, minoxidil, and tretinoin, and reported side effects from oral finasteride. They are considering switching to dutasteride or using hair fibers for better results.
community 5 months into 0.5mg Dutasteride 3x a week + 5mg Oral Minoxidil
A user is treating hair loss with 0.5mg Dutasteride three times a week, 5mg oral Minoxidil daily, and topical finasteride and minoxidil, seeing some improvement but insufficient density. They are considering increasing Dutasteride dosage and addressing high estradiol levels, while also trying to quit vaping.
Related Research
6 / 6 results
research An update on diagnosis and treatment of female pattern hair loss
This review discusses recent advances in the diagnosis and management of female pattern hair loss but reports no new clinical results.
research Telogen Effluvium
Telogen Effluvium is a hair loss condition where treatment involves identifying and managing its triggers.
research Beard Alopecia: An Updated and Comprehensive Review of Etiologies, Presentation and Treatment
This review provides a detailed overview of the causes, prevalence, pathophysiology, clinical presentation, and treatment of beard alopecia, highlighting conditions such as alopecia areata, pseudofolliculitis barbae, and tinea barbae, and aims to serve as a resource for clinicians handling such cases.
research Pilot Study of 15 Patients Receiving a New Treatment Regimen for Androgenic Alopecia: The Effects of Atopy on AGA
This pilot study found that a novel regimen including NuH Hair led to significant hair growth in male patients with androgenic alopecia, regardless of atopy status, with quicker results when additional treatment components were used.
research Platelet-Rich Plasma in Dermatology: New Insights on the Cellular Mechanism of Skin Repair and Regeneration
This article discusses the potential role of telocytes in skin regeneration and the need to understand their interaction with platelet-rich plasma, reporting no new experimental results.
research Laser-assisted Hair Regrowth
This literature review suggests that fractional laser therapies may positively impact hair regrowth in androgenic alopecia, though current evidence is mostly limited to small studies and case reports, highlighting a need for more comprehensive randomized controlled trials to confirm their efficacy and safety.